ARCT R&D to Revenue
Arcturus Therapeutics Holdings Inc · R&D to Revenue
ARCT R&D to Revenue
Latest reported166.93%period ending
ARCT FY R&D/Revenue (0.00% → 166.93%)
Latest values, visible window
High-resolution chart · PNG
ARCT r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 166.93% | |
| 141.0199% | |
| 121.7974% | |
| 71.8092% | |
| 1,405.939% | |
| 606.4158% | |
| 161.8163% | |
| 107.8017% | |
| 122.465% | |
| 90.2316% | |
| 219.306% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |